The novel therapy of tirzepatide peptide represents a significant development in the management of the condition. Distinct from existing medications, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide919316.dbblog.net/15424661/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment